Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$9,706,264
-$22,036 QoQ
Shares Held
26,804
-3.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#557
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. AMGN ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
This page
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,706,264 | 26,804 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $9,728,300 | 27,649 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $9,336,845 | 28,526 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,777,432 | 27,560 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,572,156 | 34,283 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $10,089,235 | 32,384 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,487,220 | 32,563 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,786,484 | 30,373 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $7,408,501 | 23,711 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,488,135 | 26,337 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $7,715,191 | 26,787 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,061,937 | 26,276 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,947,027 | 26,786 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,165,108 | 25,502 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,781,228 | 14,397 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,779,381 | 21,204 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $5,060,153 | 20,798 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,056,214 | 20,909 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $4,191,416 | 18,631 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,450,884 | 16,228 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,372,737 | 22,042 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,424,804 | 21,803 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,600,547 | 15,660 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $436,138 | 1,716 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $3,474,689 | 14,732 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,820,582 | 13,913 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||